47 results
424B3
SLRX
Salarius Pharmaceuticals Inc
7 Jun 23
Prospectus supplement
7:27am
will depend upon the degree of market acceptance by physicians, patients, third-party payors, and others in the medical community.
We may
8-K
EX-99.1
jtlg407w
10 Nov 22
Salarius Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
8:38am
PRE 14A
o8hd efix
15 Apr 22
Preliminary proxy
4:34pm
424B4
s9h 690o5nppkf
10 Feb 20
Prospectus supplement with pricing info
6:14am